STXS
AMEX
$1.50
Stereotaxis Inc (STXS)
Stereotaxis, Inc. designs, manufactures, and markets robotic magnetic navigation (MRI) systems for use in the hospital's interventional operating room to improve the treatment of arrhythmias and coronary artery disease in the United States and internationally. The company is headquartered in St. Louis, Missouri.
Sector:
Healthcare
Industry:
Medical Instruments & Supplies
Strong Buy
Target: $4.13 (+175.00%)
Market Cap
$160M
EPS 5Y CAGR
+27.04%
FCF 5Y CAGR
+56.19%
Free Cash Flow Yield
-9.58%
Price Chart
Valuation
Market Cap$160M
Forward P/E19.65
PEG1.31
P/S5.10
P/B11.36
Profitability
Total Revenue (TTM)$31M
Gross Profit (TTM)$17M
EBITDA-$22M
Profit Margin-93.2%
Operating Margin-95.1%
EPS-$0.24
Financial Health
Free Cash Flow Yield-9.58%
Growth & Risk
EPS 5Y CAGR+27.04%
Revenue 5Y CAGR+1.13%
FCF 5Y CAGR+56.19%
Beta (5Y)1.41
Sharpe Ratio-0.60